indirubin-3'-monoxime has been researched along with dinoprostone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jalonen, U; Kankaanranta, H; Lahti, A; Moilanen, E; Nieminen, R | 1 |
Kim, JK; Park, GM | 1 |
2 other study(ies) available for indirubin-3'-monoxime and dinoprostone
Article | Year |
---|---|
JNK inhibitor SP600125 reduces COX-2 expression by attenuating mRNA in activated murine J774 macrophages.
Topics: Animals; Anthracenes; Benzazepines; Cell Line; Cyclin-Dependent Kinase 2; Cycloheximide; Cyclooxygenase 2; Dactinomycin; Dinoprostone; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Indoles; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Macrophages; Mice; Oximes; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-jun; RNA, Messenger; Transcription, Genetic | 2006 |
Indirubin-3-monoxime exhibits anti-inflammatory properties by down-regulating NF-κB and JNK signaling pathways in lipopolysaccharide-treated RAW264.7 cells.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Cell Survival; Cyclooxygenase 2; Dinoprostone; Indoles; Inflammation; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; MAP Kinase Signaling System; Mice; NF-kappa B; Nitric Oxide Synthase Type II; Nitrites; Oximes; RNA, Messenger | 2012 |